These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9289779)

  • 21. Differences in hypolipidaemic effects of two statins on Hep G2 cells or human hepatocytes in primary culture.
    Clerc T; Sbarra V; Domingo N; Rault JP; Diaconescu N; Moutardier V; Hasselot N; Lafont H; Jadot G; Laruelle C; Chanussot F
    Br J Pharmacol; 1996 Aug; 118(7):1862-8. PubMed ID: 8842455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanisms of actions of statins and fibrates].
    Duriez P
    Therapie; 2003; 58(1):5-14. PubMed ID: 12822195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of action of absorbable hypolipidemic drugs.
    Sirtori CR
    Adv Exp Med Biol; 1985; 183():241-52. PubMed ID: 4036700
    [No Abstract]   [Full Text] [Related]  

  • 24. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
    Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
    Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of lipid-lowering statin drugs.
    Gotto AM; Hay JW
    Am J Cardiol; 1996 Jan; 77(2):225-6. PubMed ID: 8546104
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
    Desager JP; Horsmans Y
    Clin Pharmacokinet; 1996 Nov; 31(5):348-71. PubMed ID: 9118584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fluvastatin].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():587-91. PubMed ID: 11347136
    [No Abstract]   [Full Text] [Related]  

  • 29. Carcinogenicity of lipid-lowering drugs.
    Cattley RC
    JAMA; 1996 May; 275(19):1479; author reply 1481-2. PubMed ID: 8622215
    [No Abstract]   [Full Text] [Related]  

  • 30. The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.
    Roberts WC
    Am J Cardiol; 1997 Jul; 80(1):106-7. PubMed ID: 9205036
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug treatment of hypercholesterolaemia in a patient with Gilbert's syndrome.
    Cummings MH; Watts GF
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():383-5. PubMed ID: 7979108
    [No Abstract]   [Full Text] [Related]  

  • 32. [Statins in hypercholesterolemia treatment].
    Quintão EC
    Rev Assoc Med Bras (1992); 1994; 40(1):50-8. PubMed ID: 8061697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hypocholesterolaemic agents on the expression and activity of 3-hydroxy-3-methylglutaryl-CoA reductase in the fat body of the German cockroach.
    Zapata R; Martín D; Piulachs MD; Bellés X
    Arch Insect Biochem Physiol; 2002 Apr; 49(4):177-86. PubMed ID: 11921076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
    Golay A; Lehmann T; James R; Pometta D
    Schweiz Med Wochenschr; 1993 Aug; 123(33):1553-8. PubMed ID: 8372340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effects of statins.
    Rosenson RS; Tangney CC
    Lancet; 1996 Dec; 348(9041):1583. PubMed ID: 8950893
    [No Abstract]   [Full Text] [Related]  

  • 36. [Statins: similarities and differences in the pharmacological, clinical and laboratory aspects].
    Motti C; Gnasso A; Cortese C
    Ann Ital Med Int; 2000; 15(1):96-102. PubMed ID: 10842898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins do more than just lower cholesterol.
    Vaughan CJ; Murphy MB; Buckley BM
    Lancet; 1996 Oct; 348(9034):1079-82. PubMed ID: 8874463
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia.
    Milani M; Cimminiello C; Lorena M; Arpaia G; Soncini M; Bonfardeci G
    Biomed Pharmacother; 1996; 50(6-7):269-74. PubMed ID: 8952866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducers of adipose conversion activate transcription promoted by a peroxisome proliferators response element in 3T3-L1 cells.
    Brandes R; Arad R; Bar-Tana J
    Biochem Pharmacol; 1995 Nov; 50(11):1949-51. PubMed ID: 8615877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
    Yoneda T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.